Hypofractionated radiotherapy for non-metastatic bone and soft tissue sarcomas.

CONCLUSION: Hypofractionated radiotherapy as the primary treatment or for reirradiation has been shown to be safe in the treatment of bone and soft tissue sarcomas. It can provide relatively good local control and survival rates.
PMID: 31640927 [PubMed - as supplied by publisher]

Source: Cancer Radiotherapie - October 18, 2019 Category: Cancer & Oncology Authors: Yuce Sari S, Cengiz M, Dauletkazin A, Yazici G, Gultekin M, Hurmuz P, Yildiz F, Zorlu F, Gurkaynak M, Akyol F, Ozyigit G Tags: Cancer Radiother Source Type: research